NEJM - ALL

"Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia"

"CONCLUSIONS

Ph-like ALL was found to be characterized by a range of genomic alterations that activate a limited number of signaling pathways, all of which may be amenable to inhibition with approved tyrosine kinase inhibitors. Trials identifying Ph-like ALL are needed to assess whether adding tyrosine kinase inhibitors to current therapy will improve the survival of patients with this type of leukemia. (Funded by the American Lebanese Syrian Associated Charities and others."

http://www.nejm.org/doi/full/10.1056/NEJMoa1403088?query=featured_home